Fusion Antibodies plc announced that Sonya Ferguson, Non-executive Director, will not be seeking re-election at the AGM to be held on 27 October 2023, as she has decided to pursue another business opportunity. She will cease to be a Director of the Company at the close of the AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 GBX | 0.00% |
|
+1.47% | -18.82% |
May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
May. 23 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.82% | 4.17M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- FAB Stock
- News Fusion Antibodies plc
- Fusion Antibodies plc Announces Sonya Ferguson, Non-Executive Director, Will Not Be Seeking Re-Election At the AGM